EUVIMEDEUVIMED entdecken
Open Access

ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism

Ilayda Baydemir, Fabian Nikolka, Özlem Bulut, Anaísa V Ferreira, Gizem Kilic, Büsra Geckin, Robbin Kramer, Jorge Cuenca-Escalona, Evelien Floor, Marisol Báez-Magaña, Vasiliki Matzaraki, Jeroen Deckers und 14 weitere

Molecular Therapy · 2026-11 · 34 (11) · 6598-6614

DOI: 10.1016/j.ymthe.2026.08.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-11. Verfasst von Ilayda Baydemir und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Trained Immunity, Acetyl Coenzyme A, Acetyl-CoA Carboxylase, BCG Vaccine. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Netherlands Organisation for Health Research and Development, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trained immunity enhances long-term innate immune responsiveness through metabolic and epigenetic rewiring. Using Bacille Calmette-Guérin (BCG) as a model, we demonstrate that inhibition of acetyl-CoA carboxylase 1 (ACC1) enhances BCG-induced trained immunity by increasing intracellular acetyl-CoA (ACoA) availability. This shift redirects ACoA from lipid biosynthesis toward enhanced tricarboxylic acid cycle flux and histone acetylation, reinforcing metabolic and epigenetic programs that sustain trained immunity. ACC1 inhibitors amplify cytokine production, mitochondrial respiration, and glutamine metabolism in monocytes, with heightened histone H3K27 acetylation and reduced H3K9 methylation at pro-inflammatory loci. In vivo, ACC1 inhibition amplified BCG-driven myelopoiesis, increasing granulocyte-macrophage progenitors and systemic cytokine responses. Notably, genetic variation in ACoA metabolism genes influenced trained immunity responses in BCG-vaccinated individuals. These findings highlight ACC1 as a metabolic checkpoint linking cellular metabolism to innate immune memory. Targeting ACoA metabolism may represent a promising strategy to optimize vaccine efficacy and enhance broad-spectrum protection against infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trained ImmunityAcetyl Coenzyme AAcetyl-CoA CarboxylaseBCG VaccineAnimalsHumansImmunity, InnateMiceCytokinesHistonesMyelopoiesisMycobacterium bovisAcetylation

Stichwörter der Autor:innen

ACC1BCG vaccineCMS121acetyl-CoAadjuvantsimmunometabolismmetabolic reprogrammingmyelopoiesistrained immunityvaccines

Substanzen

Acetyl Coenzyme AAcetyl-CoA CarboxylaseBCG VaccineCytokinesHistones

Autor:innen und Institutionen

  • Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany.
  • Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece.
  • Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Researc…

Förderung

  • Netherlands Organisation for Health Research and Development
  • National Health and Medical Research Council

Zitieren

APA

Baydemir, I., Nikolka, F., Bulut, Ö., Ferreira, A. V., Kilic, G., Geckin, B., Kramer, R., Cuenca-Escalona, J., Floor, E., Báez-Magaña, M., Matzaraki, V., Deckers, J., Anbergen, T., van Elsas, Y., Beldman, T., Moorlag, S. J., Charlotte J de Bree, L., Spanou, V., Andriopoulou, T., …, & Domínguez-Andrés, J. (2026). ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism. Molecular Therapy, 34(11), 6598-6614. https://doi.org/10.1016/j.ymthe.2026.08.033

Vancouver

Baydemir I, Nikolka F, Bulut Ö, Ferreira AV, Kilic G, Geckin B, et al. ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism. Molecular Therapy. 2026;34(11):6598-6614. doi:10.1016/j.ymthe.2026.08.033

BibTeX
@article{Baydemir2026,
  author = {Baydemir, Ilayda and Nikolka, Fabian and Bulut, Özlem and Ferreira, Anaísa V and Kilic, Gizem and Geckin, Büsra and Kramer, Robbin and Cuenca-Escalona, Jorge and Floor, Evelien and Báez-Magaña, Marisol and Matzaraki, Vasiliki and Deckers, Jeroen and Anbergen, Tom and van Elsas, Yuri and Beldman, Thijs and Moorlag, Simone Jcfm and Charlotte J de Bree, L and Spanou, Victoria and Andriopoulou, Theano and Li, Yang and Karagianni, Evangelia and Novakovic, Boris and Sohrabi, Yahya and Joosten, Leo A B and Hiller, Karsten and Domínguez-Andrés, Jorge},
  title = {ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {11},
  pages = {6598--6614},
  doi = {10.1016/j.ymthe.2026.08.033}
}
Kostenlos starten →